太極集團(600129.SH):擬以1948萬元受讓太極國際90%股權
格隆匯3月3日丨太極集團(600129.SH)公佈,為了整合內部資源,優化股權架構與管理關係。1.公司擬以現金614萬元的價格受讓桐君閣大藥房持有的太極麒靈100%股權;2.公司擬以現金1,948萬元的價格受讓桐君閣股份持有的太極國際90%股權。
本次股權調整有利於優化公司的分類分級管理體系,工、商業板塊結構更加清晰,股權關係、管理關係、業務歸屬等保持一致,有利於整體管理效能的提升。本次股權轉讓前後,公司合併持有太極麒靈和太極國際的股權未發生變化,股權轉讓不涉及外部股東,不會導致公司合併報表範圍發生變化,不會對公司財務及經營狀況產生不利影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.